SCG101 delivers precise immune-mediated clearance of infected and malignant cells demonstrating significant tumour inhibition and the eradication of HBV covalently closed circular DNA (cccDNA) in ...

“We are pleased to announce the clearance of the '2510 IND by the FDA,” said Jamie Freedman, M.D., Ph.D., Chief Medical Officer of Instil.“Evaluating '2510 in a global population will be a ...

Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer Jun. 25, 2025 7:30 AM ET Plus Therapeutics, Inc ...

Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best biotech stocks to invest in now. On June 16, Centessa Pharmaceuticals announced that the US FDA cleared its Investigational New Drug/IND ...

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.

BOSTON and LONDON, June 16, 2025-- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration has cleared the IND to initiate ...

Thiogenesis Announces FDA Clearance of its Investigational New Drug Application ("IND") for a Phase 2a Clinical Trial in Leigh Syndrome Spectrum ...

SMARTOX deployed over 50 INBS fingerprint drug screening readers, conducting 7,000 tests, as FDA clearance for U.S. expansion is pursued.

SMARTOX has deployed 50+ fingerprint drug screening devices and completed 7,000+ tests, including 1,500 in 2024 alone. Intelligent Bio aims to expand into workplace testing pending FDA clearance ...